Xiaoyang Du

Artiklar

Article: EUROPEAN UROLOGY ONCOLOGY. 2024;:S2588-9311(24)00133-0
Effectiveness and Cost-effectiveness of Artificial Intelligence-assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study.
Du X; Hao S; Olsson H; Kartasalo K; Mulliqi N; Rai B; Menges D; Heintz E; Egevad L; Eklund M; Clements M
Article: PLOS ONE. 2024;19(8):e0308254
Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study
Rai B; Nordstrom T; Lantz A; Lund RL; Kuja-Halkola R; Rado M; Oberg S; Hao S; Du X; Clements M
Journal article: VALUE IN HEALTH. 2019;22:S914
PUK10 BUDGET IMPACT ANALYSIS OF DEGARELIX FOR THE TREATMENT OF PROSTATE CANCER IN CHINA
Du X; Fei J; Yang F; Xuan J
Journal article: VALUE IN HEALTH. 2019;22:S35-S36
CO1 A COST-UTILITY ANALYSIS OF DEGARELIX IN THE TREATMENT OF PROSTATE CANCER IN CHINA
Yang F; Du X; Xuan J; Fei J
Journal article: VALUE IN HEALTH. 2018;21:S124
PDB38 - BUDGET IMPACT ANALYSIS OF BENAGLUTIDE INJECTION IN THE TREATMENT OF TYPE 2 DIABETES IN CHINA
Deng H; Yang F; Du X; Xuan J
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY: HEART & VASCULATURE. 2018;19:90-97
Utilisation of real-world data from heart failure registries in OECD countries - A systematic review
Du X; Khamitova A; Kyhlstedt M; Sun S; Sengoelge M

Doktorand, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2022-2025